v3.25.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Cash flows from operating activities:                
Net income (loss) $ 750,303 $ (2,039,997) $ 816,754 $ 786,362   $ (1,289,691) $ 1,603,116  
Adjustments to reconcile net income (loss) to net cash used in operating activities:                
Income earned on investment held in Trust Account (88,405)   (941,850)     (185,727) (1,865,342)  
Amortized interest expense from debt discount           122,174  
Loss on issuance of FPA liability       1,929,656  
Change in fair value of FPA liability (755,837)     $ (1,123,154) (1,123,154)  
Financing expense       336,000  
Changes in current assets and liabilities:                
Accrued offering costs and expenses           44,126 69,143  
Accrued expenses - related party           64,068 4,750  
Prepaid Expenses           16,330 34,050  
Net cash used in operating activities           (86,218) (154,283)  
Cash flows from investing activities:                
Cash withdrawn from trust account in connection with redemption           67,664,408  
Net cash provided by investing activities           67,664,408  
Cash flows from financing activities:                
Payment of public shareholders’ redemption           (67,664,408)  
Net cash used in financing activities           (67,664,408)  
Net change in cash           (86,218) (154,283)  
Cash at beginning of period   103,774   $ 426,913   103,774 426,913 $ 426,913
Cash at the end of period 17,556   $ 272,630   $ 17,556 17,556 272,630 103,774
Supplemental disclosure of noncash financing activities                
Subsequent measurement of ordinary shares subject to possible redemption (income earned on trust account) $ 88,405 $ 97,321       $ 185,727 $ 1,865,342 $ 3,684,883